(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures were little changed on Wednesday as investors looked ahead to a number of economic reports that could set the tone for the fourth quarter on Wall Street. Dow Jones industrial average futures were down 0.08 percent at 16,951, S&P 500 futures were down 0.13 percent at 1,963 and Nasdaq 100 futures were down 0.23 percent at 4,035.25.
** TEKMIRA PHARMACEUTICAL CORP, Tuesday close $21.14, +29.38 pct premarket
** BIOCRYST PHARMACEUTICALS INC, Tuesday close $9.78, +12.99 pct premarket
** SAREPTA THERAPEUTICS INC, Tuesday close $21.1, +8.77 pct premarket
** NEWLINK GENETICS CORP, Tuesday close $21.42, +11.20 pct premarket
Shares of several pharmaceutical companies with potential Ebola treatments jumped after the U.S. Centers for Disease Control and Prevention confirmed the first case of the virus diagnosed in the country.
** ANGIE’S LIST INC, Tuesday close $6.37, +19.31 pct premarket
The online review company is exploring options including sale, Financial Times reported.
** WESTPORT INNOVATIONS INC, Tuesday close $10.51
The Canadian auto parts maker cut its 2014 revenue forecast to $130-$140 million, below analysts’ expectations of $178.7 million. The company also said it expects adjusted loss before interest, tax, depreciation and amortization at three operating businesses this year.
** REGAL ENTERTAINMENT GROUP, Tuesday close $19.88
** AMC ENTERTAINMENT HOLDINGS INC, Tuesday close $22.99
U.S. theater chain Regal Entertainment said it would not show the sequel to “Crouching Tiger, Hidden Dragon” in any of its IMAX theaters, objecting to a move by IMAX Corp and Netflix to side step a normal theater release.
AMC Entertainment, which manages about 150 IMAX theaters in the United States, also refused to premiere the sequel, joining the list of Regal and Cinemark, the Hollywood reporter said.
** MICROSOFT CORP, Tuesday close $46.36, -0.13 pct premarket
The internet company announced its ‘Windows 10’ operating system on Tuesday to replace the largely unpopular Windows 8, skipping a number to mark a leap toward unifying the way people work on tablets, phones and traditional computers.
** BOEING CO, Tuesday close $127.38
The U.S. Federal Aviation Administration is requiring airlines to replace cockpit displays on more than 1,300 Boeing airplanes to avoid interference from Wi-Fi and cellular devices.
** AMAZON.COM INC, Tuesday close $322.44, +0.14 pct premarket
** WALT DISNEY CO, Tuesday close $89.03
Amazon.com appears to be close to settling a nearly two-month dispute with Walt Disney Co during which Amazon stopped offering Disney DVDs for preorder, the Wall Street Journal reported on Tuesday.
** JPMORGAN CHASE & CO, Tuesday close $60.24
A federal judge on Tuesday said JPMorgan must face a class action lawsuit by investors who claimed the largest U.S. bank misled them about the safety of $10 billion of mortgage-backed securities it sold before the financial crisis.
** JOHNSON & JOHNSON, Tuesday close $106.59, -0.92 pct premarket
The diversified healthcare company agreed to pay $1.75 billion in cash to buy privately held Alios BioPharma Inc, which is developing a drug for a common respiratory viral infection in children for which there is no approved treatment.
** AMERICAN APPAREL INC, Tuesday close $0.82
The retailer’s board is increasingly open to letting its ousted founder, Dov Charney, stay at the company, Bloomberg reported, citing people familiar with the matter.
** BANK OF NEW YORK MELLON CORP, Tuesday close $38.73
The bank will exit the derivatives sales and trading business that operates as part of the company’s global markets group.
** RETROPHIN INC, Tuesday close $9.02
The drugmaker said it fired founder and Chief Executive Martin Shkreli effective immediately, the second top level change at the drugmaker this month. (Compiled by Anannya Pramanick; Edited by Maju Samuel)